Eli Lilly and Co (XSWX:LLY) Marketable Securities : CHF112 Mil (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Eli Lilly and Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Eli Lilly and Co's Marketable Securities for the quarter that ended in Mar. 2024 was CHF112 Mil.

Eli Lilly and Co's annual Marketable Securities increased from Dec. 2021 (CHF83 Mil) to Dec. 2022 (CHF135 Mil) but then declined from Dec. 2022 (CHF135 Mil) to Dec. 2023 (CHF94 Mil).

Eli Lilly and Co Marketable Securities Historical Data

The historical data trend for Eli Lilly and Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Marketable Securities Chart

Eli Lilly and Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

99.24

21.50

82.98

134.90

94.35

Eli Lilly and Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															114.21	121.19	101.75	94.35	112.05

Eli Lilly and Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Eli Lilly and Co (XSWX:LLY) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Eli Lilly and Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Eli Lilly and Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Eli Lilly and Co (XSWX:LLY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (XSWX:LLY) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

LLY:USA LLY:Mexico 1LLY:Italy LLY:Germany LLY:Canada LILY34:Brazil LLYC:Austria LLY:Argentina

Address

Lilly Corporate Center, Indianapolis, IN, USA, 46285

Website

https://www.lilly.com

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.